Cargando…
The Mouse rasH2/BHT Model as an in vivo Rapid Assay for Lung Carcinogens
We have demonstrated the utility of a 9–week in vivo two‐stage assay for lung cancer initiating agents, using transgenic mice carrying the human prototype c‐Ha‐ras gene (rasH2 mice) and butylhydroxytoluene (BHT) as a potent lung promoter (rasH2/BHT model). In the present study, to ascertain appropri...
Autores principales: | Umemura, Takashi, Kodama, Yukio, Hioki, Kyoji, Nomura, Tatsuji, Nishikawa, Akiyoshi, Hirose, Masao, Kurokawa, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927112/ https://www.ncbi.nlm.nih.gov/pubmed/12716462 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01330.x |
Ejemplares similares
-
Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
por: Yamamoto, S, et al.
Publicado: (1998) -
Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice
por: Takanashi, Seiji, et al.
Publicado: (2012) -
The implementation of security for microBHT
por: Purvis, J
Publicado: (1997) -
CORRIGENDUM: Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice
por: Takanashi, Seiji, et al.
Publicado: (2013) -
An improved financial tool to replace BHT
Publicado: (2002)